Leif Johansson: “Sweden and Ireland have many common things to discuss. We are relatively small countries, both of us. We are dependent on the rest of the world to do well.” Photograph: Simon Dawson/Bloomberg

When prominent Swedish businessman Leif Johansson first travelled the world, the Iron Curtain was up and “no one would have believed” it would come do(...)

Leif Johansson, non-executive chairman of AstraZeneca, has said clarity is needed on the UK’s future after Brexit.

AstraZeneca will keep its freeze on manufacturing investments in Britain if the country’s exit from the European Union fails to give enough clarity on(...)

Ericsson employees stand inside their booth at Mobile World Congress.

Ericsson’s new activist shareholder has hit out at the board of the struggling Swedish telecoms equipment maker as well as the influential Wallenberg (...)

Hans Vestberg: Ousted as  Ericsson chief executive  after months of criticism of Vestberg’s leadership and pay. Photograph: Albert Gea

Swedish mobile telecoms gear maker Ericsson ousted Hans Vestberg as chief executive on Monday, a move led by major shareholders after months of critic(...)

BlackRock and Schroders are among the big shareholders  that have told AstraZeneca they want the company to take a fresh look at a deal after the three-month cooling off period required under UK takeover rules.

Big shareholders in AstraZeneca have told the UK drugmaker they want the board to reopen takeover talks with Pfizer in August, after accepting that a (...)

Leif Johansson, non-executive chairman of AstraZeneca: Pfizer had “failed to make a compelling strategic, business or value case” for what would be the biggest foreign takeover of a British company.

AstraZeneca has rejected a “final” £69.4 billion takeover approach from Pfizer, triggering the biggest one-day drop in its shares on record.The Britis(...)

A ‘final’ offer from Pfizer was rejected by AstraZeneca’s board today. Photograph: Stefan Wermuth/Files/Reuters

AstraZeneca has rejected a sweetened and “final” offer from Pfizer, leaving it uncertain if the US drugmaker would pull off its plan to create the wor(...)

The furore created by Pfizer’s  £63 billion (€77 billion) bid for AstraZeneca  neared fever pitch yesterday. Photographer: Bloomberg

The furore created by the £63 billion (€77 billion) bid for Britain’s number-two pharmaceuticals group neared fever pitch yesterday, as politicians de(...)

Pfizer has opened a new $30 million unit at its Ringaskiddy facility. The New Product Technology Laboratory will allow the Cork plant to begin (...)